๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: The Australian experience

โœ Scribed by Terence C. Chua; Tristan D. Yan; David L. Morris


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
114 KB
Volume
99
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cytoreductive surgery and intraperitonea
โœ Samuel P. Jacks; Jonathan C. Hundley; Perry Shen; Greg B. Russell; Edward A. Lev ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

Introduction: Peritoneal carcinomatosis (PC) is associated with a dismal prognosis. Small bowel adenocarcinoma is a rare etiology for PC. Due to the rarity, poor prognosis, and lack of standard treatment, we chose to review our experience with this disease process treated with cytoreductive surgery

Results of cytoreductive surgery and hyp
โœ Gabriel Glockzin; Nabil Ghali; Sven A. Lang; Hans J. Schlitt; Pompiliu Piso ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB

## Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significa

Postoperative Infections in Cytoreductiv
โœ A. Capone; M. Valle; F. Proietti; O. Federici; A. Garofalo; N. Petrosillo ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

## Abstract ## Background Peritoneal carcinomatosis is a common evolution of many abdominal and pelvic malignancies. Over the last decade novel therapeutic approaches have emerged combining cytoreductive surgery with perioperative intraperitoneal chemotherapy. Aim of our study was to assess freque